<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39378229</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>08</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>24</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>10</Issue><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Differences in SARS-CoV-2 antibody prevalence at the end of the pre-vaccination period between age groups: A cross-sectional analysis of the multi-ethnic population-based HELIUS study.</ArticleTitle><Pagination><StartPage>e0311196</StartPage><MedlinePgn>e0311196</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0311196</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0311196</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">During the first waves of the COVID-19 pandemic, SARS-CoV-2 antibody prevalence (seroprevalence) was lower in older compared to younger adults. We studied age group differences in SARS-CoV-2 seroprevalence, across ethnic groups, and assessed the explanatory value of factors that increase the exposure to the virus, and factors related to susceptibility, given the level of exposure.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We analysed cross-sectional data from 2,064 participants from the multi-ethnic HELIUS study (Amsterdam, The Netherlands). SARS-CoV-2 seroprevalence at the second wave of infections was compared between age groups (&lt;40, 40-54, and ≥55 years), within ethnic groups, using Poisson regression with robust standard errors. To determine whether age group differences were explained by differences in exposure and in susceptibility, we sequentially adjusted for exposure (job setting, occupation level, health literacy, household size, household member with suspected infection), education level, and susceptibility (vitamin D intake, BMI, systolic blood pressure, haemoglobin level, number of comorbidities).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">SARS-CoV-2 seroprevalence did not statistically differ across age groups (p&gt;0.05), but age patterns varied across ethnic groups. Age group differences in SARS-CoV-2 seroprevalence were most pronounced in the Dutch majority group, with the highest prevalence ratio in the youngest group (2.55, 95%CI 0.93-6.97) and the lowest in the oldest group (0.53, 95%CI 0.16-1.74), compared to the middle-aged group. In ethnic minority groups, age group differences were smaller. In all groups, patterns did not substantially change after adjustments for exposure and susceptibility variables.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">We found no evidence of age group differences in SARS-CoV-2 seroprevalence, particularly for ethnic minority groups, even when accounting for exposure and susceptibility. While early prevention strategies particularly aimed at protecting older adults against SARS-CoV-2 infections, seroprevalence was similar across age groups in ethnic minority groups. Thus, older adults in ethnic minority groups may pose a target group for additional prevention strategies for future infectious disease outbreaks.</AbstractText><CopyrightInformation>Copyright: © 2024 Bolijn et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bolijn</LastName><ForeName>Renee</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Public and Occupational Health, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spijkerman</LastName><ForeName>Annemieke M W</ForeName><Initials>AMW</Initials><AffiliationInfo><Affiliation>Centre for Prevention, Lifestyle and Health, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Galenkamp</LastName><ForeName>Henrike</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-5904-3465</Identifier><AffiliationInfo><Affiliation>Department of Public and Occupational Health, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blokstra</LastName><ForeName>Anneke</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centre for Prevention, Lifestyle and Health, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coyer</LastName><ForeName>Liza</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectious Diseases, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boyd</LastName><ForeName>Anders</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectious Diseases, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Stichting HIV Monitoring, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prins</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectious Diseases, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stronks</LastName><ForeName>Karien</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Public and Occupational Health, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="Y">Antibodies, Viral</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005006" MajorTopicYN="Y">Ethnicity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009426" MajorTopicYN="N" Type="Geographic">Netherlands</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016036" MajorTopicYN="N">Seroepidemiologic Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>3</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>8</Day><Hour>22</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>8</Day><Hour>22</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>8</Day><Hour>13</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39378229</ArticleId><ArticleId IdType="pmc">PMC11460694</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0311196</ArticleId><ArticleId IdType="pii">PONE-D-24-05754</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization. WHO Coronavirus (COVID-19) Dashboard 2022 [Available from: https://covid19.who.int/].</Citation></Reference><Reference><Citation>Bobrovitz N, Arora RK, Cao C, Boucher E, Liu M, Donnici C, et al.. Global seroprevalence of SARS-CoV-2 antibodies: A systematic review and meta-analysis. PloS one. 2021;16(6):e0252617. doi: 10.1371/journal.pone.0252617</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0252617</ArticleId><ArticleId IdType="pmc">PMC8221784</ArticleId><ArticleId IdType="pubmed">34161316</ArticleId></ArticleIdList></Reference><Reference><Citation>Rostami A, Sepidarkish M, Fazlzadeh A, Mokdad AH, Sattarnezhad A, Esfandyari S, et al.. Update on SARS-CoV-2 seroprevalence: regional and worldwide. Clin Microbiol Infect. 2021;27(12):1762–71. doi: 10.1016/j.cmi.2021.09.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.09.019</ArticleId><ArticleId IdType="pmc">PMC8548624</ArticleId><ArticleId IdType="pubmed">34582980</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaselli NM, Hungerford D, Shenton B, Khashkhusha A, Cunliffe NA, French N. The seroprevalence of SARS-CoV-2 during the first wave in Europe 2020: A systematic review. PloS one. 2021;16(11):e0250541. doi: 10.1371/journal.pone.0250541</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0250541</ArticleId><ArticleId IdType="pmc">PMC8562786</ArticleId><ArticleId IdType="pubmed">34727115</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, Chen Z, Azman AS, Deng X, Sun R, Zhao Z, et al.. Serological evidence of human infection with SARS-CoV-2: a systematic review and meta-analysis. Lancet Glob Health. 2021;9(5):e598–e609. doi: 10.1016/S2214-109X(21)00026-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2214-109X(21)00026-7</ArticleId><ArticleId IdType="pmc">PMC8049592</ArticleId><ArticleId IdType="pubmed">33705690</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao Yd, Ding M, Dong X, Zhang Jj, Kursat Azkur A, Azkur D, et al.. Risk factors for severe and critically ill COVID‐19 patients: a review. Allergy. 2021;76(2):428–55. doi: 10.1111/all.14657</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.14657</ArticleId><ArticleId IdType="pubmed">33185910</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Klein SL, Garibaldi BT, Li H, Wu C, Osevala NM, et al.. Aging in COVID-19: Vulnerability, immunity and intervention. Ageing Res Rev. 2021;65:101205. doi: 10.1016/j.arr.2020.101205</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arr.2020.101205</ArticleId><ArticleId IdType="pmc">PMC7604159</ArticleId><ArticleId IdType="pubmed">33137510</ArticleId></ArticleIdList></Reference><Reference><Citation>Dessie ZG, Zewotir T. Mortality-related risk factors of COVID-19: a systematic review and meta-analysis of 42 studies and 423,117 patients. BMC Infect Dis. 2021;21(1):1–28.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8380115</ArticleId><ArticleId IdType="pubmed">34418980</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikolich-Zugich J, Knox KS, Rios CT, Natt B, Bhattacharya D, Fain MJ. SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes. Geroscience. 2020;42(2):505–14. doi: 10.1007/s11357-020-00186-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11357-020-00186-0</ArticleId><ArticleId IdType="pmc">PMC7145538</ArticleId><ArticleId IdType="pubmed">32274617</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstein E, Lipsitch M, Cevik M. On the Effect of Age on the Transmission of SARS-CoV-2 in Households, Schools, and the Community. J Infect Dis. 2021;223(3):362–9. doi: 10.1093/infdis/jiaa691</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiaa691</ArticleId><ArticleId IdType="pmc">PMC7665686</ArticleId><ArticleId IdType="pubmed">33119738</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang S, Yang Z, Li Z-N, Chen Z-L, Yue S-J, Fu R-J, et al.. Are older people really more susceptible to SARS-CoV-2? Aging Dis. 2022;13(5).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9466979</ArticleId><ArticleId IdType="pubmed">36186126</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikolich-Žugich J. The twilight of immunity: emerging concepts in aging of the immune system. Nat Immunol. 2018;19(1):10–9. doi: 10.1038/s41590-017-0006-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-017-0006-x</ArticleId><ArticleId IdType="pubmed">29242543</ArticleId></ArticleIdList></Reference><Reference><Citation>Scalsky RJ, Chen Y-J, Desai K, O’Connell JR, Perry JA, Hong CC. Baseline cardiometabolic profiles and SARS-CoV-2 infection in the UK Biobank. PLoS One. 2021;16(4):e0248602. doi: 10.1371/journal.pone.0248602</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0248602</ArticleId><ArticleId IdType="pmc">PMC8016301</ArticleId><ArticleId IdType="pubmed">33793566</ArticleId></ArticleIdList></Reference><Reference><Citation>Chatterji S, Byles J, Cutler D, Seeman T, Verdes E. Health, functioning, and disability in older adults—present status and future implications. Lancet. 2015;385(9967):563–75. doi: 10.1016/S0140-6736(14)61462-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(14)61462-8</ArticleId><ArticleId IdType="pmc">PMC4882096</ArticleId><ArticleId IdType="pubmed">25468158</ArticleId></ArticleIdList></Reference><Reference><Citation>Wise T, Zbozinek TD, Michelini G, Hagan CC, Mobbs D. Changes in risk perception and self-reported protective behaviour during the first week of the COVID-19 pandemic in the United States. R Soc Open Sci. 2020;7(9):200742. doi: 10.1098/rsos.200742</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rsos.200742</ArticleId><ArticleId IdType="pmc">PMC7540790</ArticleId><ArticleId IdType="pubmed">33047037</ArticleId></ArticleIdList></Reference><Reference><Citation>Niedzwiedz CL, O’Donnell CA, Jani BD, Demou E, Ho FK, Celis-Morales C, et al.. Ethnic and socioeconomic differences in SARS-CoV-2 infection: prospective cohort study using UK Biobank. BMC med. 2020;18(1):1–14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7255908</ArticleId><ArticleId IdType="pubmed">32466757</ArticleId></ArticleIdList></Reference><Reference><Citation>Coyer L, Boyd A, Schinkel J, Agyemang C, Galenkamp H, Koopman AD, et al.. Differences in SARS-CoV-2 infections during the first and second wave of SARS-CoV-2 between six ethnic groups in Amsterdam, the Netherlands: A population-based longitudinal serological study. Lancet Reg Health Eur. 2022;13:100284. doi: 10.1016/j.lanepe.2021.100284</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100284</ArticleId><ArticleId IdType="pmc">PMC8668416</ArticleId><ArticleId IdType="pubmed">34927120</ArticleId></ArticleIdList></Reference><Reference><Citation>Siddiq S, Ahmed S, Akram I. Clinical outcomes following COVID-19 infection in ethnic minority groups in the UK: a systematic review and meta-analysis. Pub Health. 2023;222:205–14. doi: 10.1016/j.puhe.2022.05.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.puhe.2022.05.019</ArticleId><ArticleId IdType="pmc">PMC9181265</ArticleId><ArticleId IdType="pubmed">35970621</ArticleId></ArticleIdList></Reference><Reference><Citation>Agyemang C, Richters A, Jolani S, Hendriks S, Zalpuri S, Yu E, et al.. Ethnic minority status as social determinant for COVID-19 infection, hospitalisation, severity, ICU admission and deaths in the early phase of the pandemic: a meta-analysis. BMJ Glob Health. 2021;6(11). doi: 10.1136/bmjgh-2021-007433</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2021-007433</ArticleId><ArticleId IdType="pmc">PMC8573300</ArticleId><ArticleId IdType="pubmed">34740916</ArticleId></ArticleIdList></Reference><Reference><Citation>Irizar P, Pan D, Kapadia D, Bécares L, Sze S, Taylor H, et al.. Ethnic inequalities in COVID-19 infection, hospitalisation, intensive care admission, and death: a global systematic review and meta-analysis of over 200 million study participants. EClinicalMedicine. 2023;57.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9986034</ArticleId><ArticleId IdType="pubmed">36969795</ArticleId></ArticleIdList></Reference><Reference><Citation>Razai MS, Kankam HK, Majeed A, Esmail A, Williams DR. Mitigating ethnic disparities in covid-19 and beyond. BMJ. 2021; 372:m4921. doi: 10.1136/bmj.m4921</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m4921</ArticleId><ArticleId IdType="pubmed">33446485</ArticleId></ArticleIdList></Reference><Reference><Citation>Raisi-Estabragh Z, McCracken C, Bethell MS, Cooper J, Cooper C, Caulfield MJ, et al.. Greater risk of severe COVID-19 in Black, Asian and Minority Ethnic populations is not explained by cardiometabolic, socioeconomic or behavioural factors, or by 25 (OH)-vitamin D status: study of 1326 cases from the UK Biobank. J Pub Health. 2020;42(3):451–60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7449237</ArticleId><ArticleId IdType="pubmed">32556213</ArticleId></ArticleIdList></Reference><Reference><Citation>Vahidy FS, Nicolas JC, Meeks JR, Khan O, Pan A, Jones SL, et al.. Racial and ethnic disparities in SARS-CoV-2 pandemic: analysis of a COVID-19 observational registry for a diverse US metropolitan population. BMJ open. 2020;10(8):e039849. doi: 10.1136/bmjopen-2020-039849</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-039849</ArticleId><ArticleId IdType="pmc">PMC7418666</ArticleId><ArticleId IdType="pubmed">32784264</ArticleId></ArticleIdList></Reference><Reference><Citation>UK Government. Drivers of the higher COVID-19 incidence, morbidity and mortality among minority ethnic groups. 23 September 2020. Paper by the ethnicity sub-group of the Scientific Advisory Group for Emergencies (SAGE; ).</Citation></Reference><Reference><Citation>Guerrero LR, Wallace SP. The impact of COVID-19 on diverse older adults and health equity in the United States. Front Pub Health. 2021:556. doi: 10.3389/fpubh.2021.661592</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2021.661592</ArticleId><ArticleId IdType="pmc">PMC8165264</ArticleId><ArticleId IdType="pubmed">34079786</ArticleId></ArticleIdList></Reference><Reference><Citation>Zelner J, Trangucci R, Naraharisetti R, Cao A, Malosh R, Broen K, et al.. Racial disparities in coronavirus disease 2019 (COVID-19) mortality are driven by unequal infection risks. Clin Infect Dis. 2021;72(5):e88–e95. doi: 10.1093/cid/ciaa1723</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1723</ArticleId><ArticleId IdType="pmc">PMC7717213</ArticleId><ArticleId IdType="pubmed">33221832</ArticleId></ArticleIdList></Reference><Reference><Citation>Coyer L, Boyd A, Schinkel J, Agyemang C, Galenkamp H, Koopman AD, et al.. SARS-CoV-2 antibody prevalence and correlates of six ethnic groups living in Amsterdam, the Netherlands: a population-based cross-sectional study, June–October 2020. BMJ open. 2022;12(1):e052752. doi: 10.1136/bmjopen-2021-052752</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2021-052752</ArticleId><ArticleId IdType="pmc">PMC8739540</ArticleId><ArticleId IdType="pubmed">34992110</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu T, Mack JA, Salvatore M, Sankar SP, Valley TS, Singh K, et al.. Characteristics associated with racial/ethnic disparities in COVID-19 outcomes in an academic health care system. JAMA netw open. 2020;3(10):e2025197-e.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7578774</ArticleId><ArticleId IdType="pubmed">33084902</ArticleId></ArticleIdList></Reference><Reference><Citation>(RIVM) NIfPHatE. Tijdlijn van coronamaatregelen 2020 2023 [Available from: https://www.rivm.nl/gedragsonderzoek/tijdlijn-van-coronamaatregelen-2020].</Citation></Reference><Reference><Citation>Stronks K, Snijder MB, Peters RJ, Prins M, Schene AH, Zwinderman AH. Unravelling the impact of ethnicity on health in Europe: The HELIUS study. BMC Pub Health. 2013;13(402):1–10. doi: 10.1186/1471-2458-13-402</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2458-13-402</ArticleId><ArticleId IdType="pmc">PMC3646682</ArticleId><ArticleId IdType="pubmed">23621920</ArticleId></ArticleIdList></Reference><Reference><Citation>Snijder MB, Galenkamp H, Prins M, Derks EM, Peters RJ, Zwinderman AH, et al.. Cohort profile: The Healthy Life in an Urban Setting (HELIUS) study in Amsterdam, the Netherlands. BMJ Open. 2017;7(12):e017873. doi: 10.1136/bmjopen-2017-017873</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2017-017873</ArticleId><ArticleId IdType="pmc">PMC5736025</ArticleId><ArticleId IdType="pubmed">29247091</ArticleId></ArticleIdList></Reference><Reference><Citation>Stronks K, Kulu-Glasgow I, Agyemang C. The utility of ‘country of birth’for the classification of ethnic groups in health research: the Dutch experience. Ethn health. 2009;14(3):255–69. doi: 10.1080/13557850802509206</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13557850802509206</ArticleId><ArticleId IdType="pubmed">19052941</ArticleId></ArticleIdList></Reference><Reference><Citation>GeurtsvanKessel CH, Okba NMA, Igloi Z, et al.. An evaluation of COVID-19 serological assays informs future diagnostics and exposure assessment. Nat Comm. 2020. 11, 3436. doi: 10.1038/s41467-020-17317-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-17317-y</ArticleId><ArticleId IdType="pmc">PMC7338506</ArticleId><ArticleId IdType="pubmed">32632160</ArticleId></ArticleIdList></Reference><Reference><Citation>Fransen M, Van Schaik T, Twickler T, Essink-Bot M. Applicability of internationally available health literacy measures in the Netherlands. J health comm. 2011;16(sup3):134–49. doi: 10.1080/10810730.2011.604383</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10810730.2011.604383</ArticleId><ArticleId IdType="pubmed">21951248</ArticleId></ArticleIdList></Reference><Reference><Citation>Kullberg RF, Haak BW, Abdel-Aziz MI, Davids M, Hugenholtz F, Nieuwdorp M, et al.. Gut microbiota of adults with asthma is broadly similar to non-asthmatics in a large population with varied ethnic origins. Gut Microbes. 2021;13(1):1995279. doi: 10.1080/19490976.2021.1995279</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19490976.2021.1995279</ArticleId><ArticleId IdType="pmc">PMC8583066</ArticleId><ArticleId IdType="pubmed">34743654</ArticleId></ArticleIdList></Reference><Reference><Citation>Team R. RStudio: Integrated Development for R. Boston, MA: RStudio, Inc.; 2016.</Citation></Reference><Reference><Citation>Bowleg L. The problem with the phrase women and minorities: Intersectionality—an important theoretical framework for public health. Am J Pub Health. 2012;102(7):1267–73. doi: 10.2105/AJPH.2012.300750</Citation><ArticleIdList><ArticleId IdType="doi">10.2105/AJPH.2012.300750</ArticleId><ArticleId IdType="pmc">PMC3477987</ArticleId><ArticleId IdType="pubmed">22594719</ArticleId></ArticleIdList></Reference><Reference><Citation>Government of the Netherlands. Maart 2020: Maatregelen tegen verspreiding coronavirus, intelligente lockdown 2022 [Available from: https://www.rijksoverheid.nl/onderwerpen/coronavirus-tijdlijn/maart-2020-maatregelen-tegen-verspreiding-coronavirus].</Citation></Reference><Reference><Citation>Atchison C, Bowman LR, Vrinten C, Redd R, Pristerà P, Eaton J, et al.. Early perceptions and behavioural responses during the COVID-19 pandemic: a cross-sectional survey of UK adults. BMJ open. 2021;11(1):e043577. doi: 10.1136/bmjopen-2020-043577</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-043577</ArticleId><ArticleId IdType="pmc">PMC7783373</ArticleId><ArticleId IdType="pubmed">33397669</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhala N, Curry G, Martineau AR, Agyemang C, Bhopal R. Sharpening the global focus on ethnicity and race in the time of COVID-19. Lancet. 2020;395(10238):1673–6. doi: 10.1016/S0140-6736(20)31102-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)31102-8</ArticleId><ArticleId IdType="pmc">PMC7211499</ArticleId><ArticleId IdType="pubmed">32401716</ArticleId></ArticleIdList></Reference><Reference><Citation>Chilunga FP, Campman S., Galenkamp H. et al.. Relative contributions of pre-pandemic factors and intra-pandemic activities to differential COVID-19 risk among migrant and non-migrant populations in the Netherlands: lessons for future pandemic preparedness. Int J Equity Health. 2023; 22, 127 doi: 10.1186/s12939-023-01936-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12939-023-01936-0</ArticleId><ArticleId IdType="pmc">PMC10320885</ArticleId><ArticleId IdType="pubmed">37403097</ArticleId></ArticleIdList></Reference><Reference><Citation>Bachour Y, Wynberg E, Coyer L, Buster M, Schreijer A, van Duijnhoven Y, et al.. COVID-19 burden differed by city districts and ethnicities during the pre-vaccination era in Amsterdam, the Netherlands. Front Public Health. 2023;11:1166193. doi: 10.3389/fpubh.2023.1166193</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2023.1166193</ArticleId><ArticleId IdType="pmc">PMC10326320</ArticleId><ArticleId IdType="pubmed">37427262</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathur R, Rentsch CT, Morton CE, Hulme WJ, Schultze A, MacKenna B, et al.. Ethnic differences in SARS-CoV-2 infection and COVID-19-related hospitalisation, intensive care unit admission, and death in 17 million adults in England: an observational cohort study using the OpenSAFELY platform. Lancet. 2021;397(10286):1711–24. doi: 10.1016/S0140-6736(21)00634-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)00634-6</ArticleId><ArticleId IdType="pmc">PMC8087292</ArticleId><ArticleId IdType="pubmed">33939953</ArticleId></ArticleIdList></Reference><Reference><Citation>Magesh S, John D, Li WT, Li Y, Mattingly-App A, Jain S, et al.. Disparities in COVID-19 outcomes by race, ethnicity, and socioeconomic status: a systematic-review and meta-analysis. JAMA netw open. 2021;4(11):e2134147-e. doi: 10.1001/jamanetworkopen.2021.34147</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.34147</ArticleId><ArticleId IdType="pmc">PMC8586903</ArticleId><ArticleId IdType="pubmed">34762110</ArticleId></ArticleIdList></Reference><Reference><Citation>Crawshaw AF, Farah Y, Deal A, Rustage K, Hayward SE, Carter J, et al.. Defining the determinants of vaccine uptake and undervaccination in migrant populations in Europe to improve routine and COVID-19 vaccine uptake: a systematic review. Lancet Infect Dis. 2022;22(9):e254–e66. doi: 10.1016/S1473-3099(22)00066-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(22)00066-4</ArticleId><ArticleId IdType="pmc">PMC9007555</ArticleId><ArticleId IdType="pubmed">35429463</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>